Arkolith/Insider Trading/VRCA/Form 4

Manning Paul B

Director, 10% OwnerVerrica Pharmaceuticals Inc. (VRCA) · full profile →Form 4 · filed Sep 23, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 19, 2024Gift(G)892K—$0892K
Sep 19, 2024Gift(G)892K—$0892K
Sep 19, 2024Gift(G)892K—$0892K
Sep 19, 2024Gift(G)2.7M—$00

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-023835) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML